drugset / Trial / NCT00262379

Use or Non-use of Epoetin Beta in Patients Infected by Chronic Hepatitis C

NCT00262379

Phase 3 Completed 229 enrolled University Hospital, Angers
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose is to demonstrate a correction of anemia in hepatitis C virus treatment with peginterferon plus ribavirin.

Timeline

Start
2005-12
Primary completion
2009-06
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator epoetin alfa Protein / enzyme biologic